Approval · Notice of Compliance 19603 · 2017
NAROPIN: Notice of Compliance 19603
Issued July 28, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19603
- Date
- July 28, 2017
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
Medicinal ingredients
- ROPIVACAINE HYDROCHLORIDE 2 MG per ML
- ROPIVACAINE HYDROCHLORIDE 5 MG per ML
- ROPIVACAINE HYDROCHLORIDE 10 MG per ML